Pulmatrix Inc (PULM)

[Fress]

PULM

iSPERSE™ can efficiently deliver small molecules, drug combinations, peptides, proteins, and nucleic acids via the respiratory system

virus
Can be used with a broad range of drugs, small molecule to biologic

lungs
Can deliver large doses into lungs (tens of milligrams) with high lung delivery efficiency

inhaler
Can be used with any device (ie, metered-dose, reservoir, or blister-based inhalers)

liver
Avoids first-pass effect and systemic side-effects, with improved PK profile compared to oral delivery

people
Can be administered to all patients due to its high dispersibility over a wide range of flow rates allowing for efficient penetration deep into the lung

chart
Broad IP portfolio into 2030s

http://www.pulmatrix.com/

20 Million Market Cap partnerships with Johnson & Johnson & Cipla Indias 2nd largest pharmaceutical company tick tock tick tock
https://ir.pulmatrix.com/2020-01-02-Pulmatrix-Announces-Kinase-Inhibitor-Licensing-Agreement-with-Lung-Cancer-Initiative-at-Johnson-Johnson


$PULM